ID
25706
Description
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Keywords
Versions (4)
- 8/31/17 8/31/17 -
- 9/4/17 9/4/17 -
- 9/4/17 9/4/17 -
- 9/11/17 9/11/17 -
Uploaded on
September 11, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
visit screening, period 1, 2, 3, 4 & final examination pregnancy PK and tolerability of ropinirole as 5 new formulations 101468/197
visit screening, period 1, 2, 3, 4 & final examination pregnancy PK and tolerability of ropinirole as 5 new formulations 101468/197
Description
SERUM PREGNANCY TEST
Alias
- UMLS CUI-1
- C0430060
Description
pregnancy test
Data type
text
Alias
- UMLS CUI [1]
- C0032976
Description
time of pregnancy test
Data type
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0032976
Description
If "other", specify.
Data type
text
Alias
- UMLS CUI [1,1]
- C0032976
- UMLS CUI [1,2]
- C0884358
Description
pregnancy test result
Data type
text
Alias
- UMLS CUI [1,1]
- C0032976
- UMLS CUI [1,2]
- C1274040
Similar models
visit screening, period 1, 2, 3, 4 & final examination pregnancy PK and tolerability of ropinirole as 5 new formulations 101468/197
C0032976 (UMLS CUI [1,2])
C0884358 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])
No comments